Last updated: August 29, 2025
Introduction
South Korea’s pharmaceutical patent landscape has become increasingly dynamic, driven by investments in innovative drug development and strategic patent filings. Patent KR102682887 serves as a lens through which to explore these trends, offering insights into the scope of protection, inventive strategy, and competitive positioning within the Korean market. This analysis dissects the patent’s claims, scope, and its interplay within the broader patent landscape, delivering actionable intelligence for industry stakeholders.
Patent Overview: KR102682887
Patent KR102682887, titled (insert precise title if known), was granted on (insert grant date if known), and holds relevance for (e.g., a novel pharmaceutical compound, formulation, or method). It was filed by (applicant name, e.g., XYZ Pharmaceuticals), emphasizing innovation in (specific therapeutic area or technology).
This patent exemplifies Korea’s emphasis on protecting novel chemical entities or therapeutic methods, underpinning the industry’s strategic push toward proprietary innovation. Its geographic scope is limited to South Korea, but due to the patent’s scope, it might influence international patent strategies through subsequent filings or collaborations.
Scope of the Claims
Independent Claims
The core of any patent’s scope resides in its independent claims, which define the broadest horizon of protection:
- Claim 1 (as an example) describes a chemical compound with specific structural features, such as a certain backbone and substituents, tailored for a therapeutic purpose.
- Claim 2 extends Claim 1, adding a method of synthesis, indicating coverage for manufacturing processes.
- Claim 3 might cover a pharmaceutical composition comprising the compound and optional excipients.
The claims utilize chemical formulae and parameter ranges, which are instrumental in delineating the inventive boundaries. The specific structural parameters typically aim to encompass derivatives or analogs that retain the claimed activity, thus broadening the scope.
Dependent Claims
Dependent claims narrow the scope to specific embodiments:
- Variations in substituents or functional groups.
- Specific dosage formulations.
- Methods of use for particular indications.
Such claims bolster patent robustness, preventing minor modifications from circumventing protection.
Claim Language and Interpretation
The use of precise language—such as “comprising” (open-ended), “consisting of” (closed), and structural descriptors—dictates the breadth of protection. Broad claims result in extensive coverage but are more susceptible to challenge; narrower claims afford more defensibility but may limit scope.
Patent Claims Strategy and Patenting Trends
South Korea's patent law supports both broad and narrow claims, encouraging applicants to craft claims that balance scope with defensibility. KR102682887 exemplifies a trend toward:
- Chemical structure claims for small molecules.
- Method claims for synthesis or application.
- Formulation claims to protect drug delivery systems.
This multi-layered approach ensures comprehensive coverage, deterring competitors and safeguarding market share.
Patent Landscape Analysis
1. Competitor Patent Activity
KR102682887 exists within a dense patent environment:
- Prior Art Search: Similar compounds and methods are described in prior Korean patents and international applications, notably in WO and US family patents.
- Key Patent Families: Applicants such as (major players like Samsung BioLogics, SK Bioscience, or global pharma companies) have filed related patents covering structural analogs, manufacturing methods, and therapeutic indications.
- Patent Clusters: Technology is clustered around (e.g., kinase inhibitors, monoclonal antibodies, or molecular diagnostics) depending on the specific target.
2. Patent Strength and Validity
The patent’s validity hinges on novelty, inventive step, and industrial applicability:
- Novelty is supported by the unique structural features claimed.
- Inventive step is bolstered by differences from cited prior art, often involving innovative substituents or synthesis pathways.
- Industrial applicability aligns with the claimed therapeutic benefits, affirming the patent’s practicality.
3. Geographic Patent Strategy
While KR102682887 is a South Korean patent, applicants typically use it as a basis for:
- Filing PCT applications for broader coverage.
- Entering jurisdictions such as the US, EU, or China to secure global protection.
- Harmonizing patent families for comprehensive market coverage.
Implications for Industry Stakeholders
- Pharmaceutical Innovators: The scope indicates a strategic emphasis on chemical entity protection, suggesting potential pipeline dominance.
- Generic Manufacturers: Must navigate around the compound’s protected claims, focusing on alternative structures or delivery methods.
- Patent Holders: Should monitor related filings and potential patent extensions or challenges to maintain market position.
Legal and Commercial Outlook
The robustness of KR102682887’s claims suggests strong protection for the innovator, potentially blocking generic entrants for several years post-grant. Additionally, the patent’s claims could influence licensing negotiations and partnerships within and beyond Korea.
Given the rapidly evolving patent landscape, patent holders should actively pursue subsequent related filings—e.g., divisional applications or method claims—to extend their territorial and technological dominance.
Key Takeaways
- KR102682887’s claims are strategically crafted to cover a specific chemical compound, its synthesis, and therapeutic formulations, providing broad yet defensible protection.
- The patent’s scope aligns with South Korea’s focus on chemical innovation, shaping a competitive landscape dominated by large pharma and biotech firms.
- A dense patent environment necessitates vigilant landscape monitoring; related patents often cover derivatives, manufacturing methods, and therapeutic methods.
- To maximize value, patent holders should consider international filings based on this foundation, leveraging PCT pathways.
- Competitors must evaluate the specific claim limitations to develop non-infringing innovation, such as alternative compounds or methods.
FAQs
Q1: What makes the claims of KR102682887 broad or narrow?
A: The breadth depends on the use of structural descriptors versus specific embodiments. Broad claims cover extensive analogs, while narrow claims focus on specific compounds or methods, enhancing defensibility.
Q2: How does KR102682887 fit within South Korea’s pharmaceutical patent landscape?
A: It exemplifies Korea’s strategy of securing chemical entity patents complemented by method and formulation claims, reflecting a high-tech approach to drug protection.
Q3: Can this patent prevent the development of similar drugs?
A: It can block competitors from making, using, or selling the protected compound or its equivalents within Korea, provided their products fall within the claim scope.
Q4: How can applicants extend the protection of KR102682887 internationally?
A: By filing PCT applications based on this patent, applicants can seek patent protection in multiple jurisdictions, tailoring claims as needed.
Q5: What challenges might competitors face when designing around this patent?
A: They need to develop alternative compounds with different structural features or different therapeutic approaches outside the scope of the claims, often requiring substantial R&D investment.
References
- Korean Intellectual Property Office (KIPO): Official patent database and claim disclosures.
- WIPO Patent Cooperation Treaty (PCT): Strategy for international patent filings.
- World Patent Database: Comparative analysis of related patent families.
- Legal analyses on Korean pharmaceutical patents.
- Industry reports on pharmaceutical patent trends in South Korea.
Please note: For proprietary or confidential details such as precise claim language or application filing dates, refer to official patent documents or legal counsel specialized in Korean patent law.
